Publicly listed US equity real estate investment trusts closed Jan. 31 at a median 13.8% discount to their consensus net ...

Rolph Timothy, the Chief Scientific Officer of Akero Therapeutics Inc . (NASDAQ:AKRO), recently executed a notable share sale, as per the latest SEC filing. The timing is particularly interesting as ...

Given the ongoing challenges in the Hi-Tech and TMT sectors ICICI Securities said they maintain a cautiously optimistic ...

SES AI's innovative business model, combining subscription and product revenue, is expected to yield high margins and ...